Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunom...
Q1 2026
Mar 31, 2026
FY 2025
Dec 31, 2025
Q4 2025
Q3 2025
Nov 19, 2025
Q2 2025
Aug 19, 2025